Can new models of financing allow solid tumor research and development to move more quickly? Non-profits are willing to place their bets on new ideas that may not otherwise be funded. Corporate ventures are moving into earlier research. Consortia are leveraging funds to remove roadblocks and drive efficiencies to get to the clinic faster. Take a look at successful models for untraditional funding sources.